CPC A61K 31/635 (2013.01) [A61K 9/0014 (2013.01); A61K 9/06 (2013.01); A61K 31/045 (2013.01); A61K 31/125 (2013.01); A61K 36/61 (2013.01); A61K 38/1808 (2013.01); A61K 47/06 (2013.01); A61K 47/10 (2013.01)] | 3 Claims |
1. A topical formulation, comprising:
(a) at least about 1% silver sulfadiazine;
(b) at least about 0.001% urogastrone; and
(c) an ingredient selected from the group consisting of:
(1) camphor;
(2) menthol; and
(3) eucalyptus;
wherein said ingredient selected from the group in (c) is in a concentration sufficient to provide a clinically effective increase in rate of wound healing when the topical formulation is applied to a wound.
|